Drug to slow Alzheimer’s well tolerated outside of clinical trial setting-Click Here

May 12, 2025 — In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer’s disease who received lecanemab …Read More